US and European guidelines for atrial fibrillation differ in subtle but important ways that are swaying treatment decisions.

The results showed that patients taking diltiazem had a 20% higher risk of being hospitalized or dying due to serious ...

With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for ...

Two studies led by researchers at the Broad Institute of MIT and Harvard and Mass General Brigham have greatly expanded the ...

Discover how botanical and nutrient therapies provided adjunctive support for a 76-year-old patient with treatment-resistant ...

Explore a detailed case study on a 72-year-old male with PVCs following atrial fibrillation ablation, showcasing the holistic use of Natrum muriaticum and homeopathic principles to improve ...

A new study published in JAMA has raised concerns about the safety of certain blood pressure medications for people with atrial fibrillation (AFib)—a common type of irregular heartbeat. The research ...

In 2020, Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Four years later, she and her husband, Ken, halted the treatment.

You have treatment options if your symptoms become too severe. Treatment for AFib, such as medications, nonsurgical procedures, and surgery, can slow your heartbeat and bring it back into a normal ...

For this understudied population, the findings may offer some reassurance as apixaban is already the most prescribed OAC in the general population of the U.S. and in people with H ...

It’s prescribed for weight loss and to lower cardiovascular risks. Wegovy interacts with some other drugs and certain supplements, including insulin and ACE inhibitors. An interaction occurs ...